NASHVILLE, Tenn. (February 14, 2024) — Petauri, a purpose-built pharmaceutical services platform, announced its acquisition of FORCE Communications and its 3 independent companies, DRIVE, MOMENTUM, and PROPEL, which bring science to life on behalf of clients and their medical innovations.
Rapidly growing pharmaceutical services platform expands presence in life sciences consulting with the addition of key industry leadership. NASHVILLE, Tenn. (January 18, 2024) — Petauri, a purpose-built pharmaceutical services platform, announced today the launch of Petauri Advisors, with industry veteran Steve O’Malley as President.
Rapidly growing pharmaceutical services platform expands board leadership with experts in health insurance, public health policy, and life sciences innovation. NASHVILLE, Tenn. (December 6, 2023) — Petauri Health, a purpose-built pharmaceutical services platform, announced today that two highly regarded healthcare executives, William Fleming and James Robinson, have been elected as members of the company's Board...
Rapidly growing pharmaceutical services platform enhances corporate center with key strategic talent specializing in legal and human resources matters. NASHVILLE, Tenn. (November 29, 2023) — Petauri Health, a purpose-built pharmaceutical services platform, today announced the addition of two industry professionals who expand its senior leadership team. Nicole Kline, Petauri’s new Vice President, General Counsel...
Rapidly growing Petauri Health adds exceptional talent to its executive roster. NEW YORK September 21, 2023 — Petauri Health, a New York-based, purpose-built pharmaceutical services platform, announced today that it…
Rapidly growing Petauri Health adds top talent to its executive team NEW YORK July 12, 2023 — Petauri Health, a New York–based, purpose-built pharmaceutical services platform, announced today that it…
Petauri Health’s initial acquisition marks a key milestone in its mission to offer integrated commercialization solutions. NEW YORK June 13, 2023 — Petauri Health, a New York–based, purpose-built pharmaceutical services…
PM360 asked experts in developing market access strategies how the Inflation Reduction Act will impact drug pricing negotiation and other access-related issues as well as what other big trends in the space will…
Oak Hill Capital and life sciences industry leader Dan Renick team up to create new organization offering integrated commercialization solutions. NEW YORK February 1st, 2023 - Oak Hill Capital, a…